围术期医学中机器学习工具的并发症预测与预后判断:系统综述与PROBAST评估
该系统综述由临床医生与工程师 multidisciplinary 团队按PRISMA方案检索多个数据库,纳入103项研究,评估机器学习在围术期并发症预测与预后判断中的现状、偏倚与验证局限。结果显示75%的模型仅基于单中心验证,仅13%经过多中心外部验证,多数死亡预测模型判别与分类能力有限,PROBAST评估提示预测结局与人工智能/机器学习应用存在高系统误差风险。结论认为该领域仍处早期阶段,临床转化前需先克服关键挑战。
要点
- 纳入103项研究,75%的模型仅单中心验证,仅13%经多中心外部验证。
- 多数死亡预测模型判别与分类能力有限。
- PROBAST评估提示预测结局与机器学习应用存在高系统误差风险。
核心结论
- 围术期医学中机器学习应用仍处早期阶段,虽显示潜在用途,但临床引入前需先克服关键挑战。
研究设计与样本
- 由临床医生与工程师 multidisciplinary 团队按PRISMA方案开展系统综述,检索Scopus、CINAHL、Cochrane Library、PubMed、Medline、Embase和Web of Science等数据库,共纳入103项研究。
- 综述聚焦研究设计、所用机器学习模型类型、验证技术及报告的并发症预测与预后判断模型性能,并用PROBAST评估偏倚风险与适用性。
主要发现
- 文献报告的模型主要基于单中心验证(75%),仅13%经过多中心外部验证。
- 多数死亡预测模型判别与分类能力有限。
- PROBAST评估提示预测结局与人工智能或机器学习应用存在高系统误差风险。
临床怎么用
- 临床引入机器学习预测工具前,应优先关注其是否经多中心外部验证及PROBAST偏倚风险评估结果。
- 对仅单中心验证或死亡预测判别能力有限的模型,不宜直接用于围术期临床决策。
局限性
- 原文未报告所纳入研究的具体样本量、P值、剂量或阈值等数据。
- 原文未报告各数据库的具体检索时间范围与检索策略细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The utilization of artificial intelligence and machine learning as diagnostic and predictive tools in perioperative medicine holds great promise. Indeed, many studies have been performed in recent years to explore the potential. The purpose of this systematic review is to assess the current state of machine learning in perioperative medicine, its utility in prediction of complications and prognostication, and limitations related to bias and validation. METHODS: A multidisciplinary team of clinicians and engineers conducted a systematic review using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) protocol. Multiple databases were searched, including Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Cochrane Library, PubMed, Medline, Embase, and Web of Science. The systematic review focused on study design, type of machine learning model used, validation techniques applied, and reported model performance on prediction of complications and prognostication. This review further classified outcomes and machine learning applications using an ad hoc classification system. The Prediction model Risk Of Bias Assessment Tool (PROBAST) was used to assess risk of bias and applicability of the studies. RESULTS: A total of 103 studies were identified. The models reported in the literature were primarily based on single-center validations (75%), with only 13% being externally validated across multiple centers. Most of the mortality models demonstrated a limited ability to discriminate and classify effectively. The PROBAST assessment indicated a high risk of systematic errors in predicted outcomes and artificial intelligence or machine learning applications. CONCLUSIONS: The findings indicate that the development of this field is still in its early stages. This systematic review indicates that application of machine learning in perioperative medicine is still at an early stage. While many studies suggest potential utility, several key challenges must be first overcome before their introduction into clinical practice.
引用
- Arina P, Kaczorek MR, Hofmaenner DA, et al. Prediction of Complications and Prognostication in Perioperative Medicine: A Systematic Review and PROBAST Assessment of Machine Learning Tools. Anesthesiology. 2024. PMID: 37944114. doi:10.1097/ALN.0000000000004764
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。